CDP323 Biomarker Study

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2008
Comparison of the effects of different CDP323 doses given over a period of four weeks on blood biomarkers in subjects with relapsing forms of multiple sclerosis.
Epistemonikos ID: 0c74c6ffbbb67cee41541ff50f9c47da5d5269a2
First added on: Mar 31, 2022